Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

CKD: A Call for an Age-Adapted Definition.

Delanaye P, Jager KJ, Bökenkamp A, Christensson A, Dubourg L, Eriksen BO, Gaillard F, Gambaro G, van der Giet M, Glassock RJ, Indridason OS, van Londen M, Mariat C, Melsom T, Moranne O, Nordin G, Palsson R, Pottel H, Rule AD, Schaeffner E, Taal MW, White C, Grubb A, van den Brand JAJG.

J Am Soc Nephrol. 2019 Sep 10. pii: ASN.2019030238. doi: 10.1681/ASN.2019030238. [Epub ahead of print] Review.

PMID:
31506289
2.

Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer Study.

Schulz CA, Engström G, Christensson A, Nilsson PM, Melander O, Orho-Melander M.

Kidney Int Rep. 2019 May 16;4(8):1143-1151. doi: 10.1016/j.ekir.2019.05.003. eCollection 2019 Aug.

3.

Echocardiographic Findings in Patients with Mild to Moderate Chronic Kidney Disease without Symptomatic Heart Failure: A Population-Based Study.

Xhakollari L, Leosdottir M, Magnusson M, Holzmann MJ, Nilsson PM, Christensson A.

Cardiorenal Med. 2019;9(5):284-296. doi: 10.1159/000499835. Epub 2019 Jun 25.

PMID:
31238302
4.

Complement C3 and incident hospitalization due to chronic kidney disease: a population-based cohort study.

Bao X, Borné Y, Muhammad IF, Schulz CA, Persson M, Orho-Melander M, Niu K, Christensson A, Engström G.

BMC Nephrol. 2019 Feb 21;20(1):61. doi: 10.1186/s12882-019-1248-7.

5.

Plasma kidney injury molecule-1 (p-KIM-1) levels and deterioration of kidney function over 16 years.

Schulz CA, Engström G, Nilsson J, Almgren P, Petkovic M, Christensson A, Nilsson PM, Melander O, Orho-Melander M.

Nephrol Dial Transplant. 2019 Jan 9. doi: 10.1093/ndt/gfy382. [Epub ahead of print]

PMID:
30629206
6.

Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins.

Almén MS, Björk J, Nyman U, Lindström V, Jonsson M, Abrahamson M, Vestergren AS, Lindhe Ö, Franklin G, Christensson A, Grubb A.

Kidney Int Rep. 2018 Sep 13;4(1):67-79. doi: 10.1016/j.ekir.2018.09.002. eCollection 2019 Jan.

7.

Cystatin C and creatinine-based eGFR levels and their correlation to long-term morbidity and mortality in older adults.

Werner K, Christensson A, Legrand H, Pihlsgård M, Sterner G, Elmståhl S.

Aging Clin Exp Res. 2018 Dec 17. doi: 10.1007/s40520-018-1091-x. [Epub ahead of print]

PMID:
30560432
8.

Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Yamamoto S, Karaboyas A, Komaba H, Taniguchi M, Nomura T, Bieber BA, De Sequera P, Christensson A, Pisoni RL, Robinson BM, Fukagawa M.

BMC Nephrol. 2018 Oct 5;19(1):253. doi: 10.1186/s12882-018-1056-5.

9.

Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort.

Harari F, Sallsten G, Christensson A, Petkovic M, Hedblad B, Forsgard N, Melander O, Nilsson PM, Borné Y, Engström G, Barregard L.

Am J Kidney Dis. 2018 Sep;72(3):381-389. doi: 10.1053/j.ajkd.2018.02.358. Epub 2018 Apr 23.

10.

Alterations in Serum MicroRNA Profile During Hemodialysis - Potential Biological Implications.

Trzybulska D, Eckersten D, Giwercman A, Christensson A, Tsatsanis C.

Cell Physiol Biochem. 2018;46(2):793-801. doi: 10.1159/000488737. Epub 2018 Mar 29.

11.

Plasma copeptin as a predictor of kidney disease.

Enhörning S, Christensson A, Melander O.

Nephrol Dial Transplant. 2019 Jan 1;34(1):74-82. doi: 10.1093/ndt/gfy017.

12.

The Impact of the Glomerular Filtration Rate on the Human Plasma Proteome.

Christensson A, Ash JA, DeLisle RK, Gaspar FW, Ostroff R, Grubb A, Lindström V, Bruun L, Williams SA.

Proteomics Clin Appl. 2018 May;12(3):e1700067. doi: 10.1002/prca.201700067. Epub 2018 Jan 31.

PMID:
29281176
13.

Longitudinal Assessment of PTH in Community-Dwelling Older Women-Elevations Are Not Associated With Mortality.

Buchebner D, Malmgren L, Christensson A, McGuigan F, Gerdhem P, Ridderstråle M, Åkesson K.

J Endocr Soc. 2017 Apr 19;1(6):615-624. doi: 10.1210/js.2017-00104. eCollection 2017 Jun 1.

14.

Impact of Kidney Transplantation on Reproductive Hormone Levels in Males: A Longitudinal Study.

Eckersten D, Giwercman A, Pihlsgård M, Bruun L, Christensson A.

Nephron. 2018;138(3):192-201. doi: 10.1159/000484992. Epub 2017 Dec 14.

PMID:
29248921
15.

Prevalence and determinants of differences in cystatin C and creatinine-based estimated glomerular filtration rate in community-dwelling older adults: a cross-sectional study.

Legrand H, Werner K, Christensson A, Pihlsgård M, Elmståhl S.

BMC Nephrol. 2017 Dec 4;18(1):350. doi: 10.1186/s12882-017-0759-3.

16.

Reduced kidney function is associated with BMD, bone loss and markers of mineral homeostasis in older women: a 10-year longitudinal study.

Malmgren L, McGuigan F, Christensson A, Akesson KE.

Osteoporos Int. 2017 Dec;28(12):3463-3473. doi: 10.1007/s00198-017-4221-y. Epub 2017 Oct 16. Review.

17.

Renal function and its association with blood pressure in Middle Eastern immigrants and native Swedes.

Nilsson C, Christensson A, Nilsson PM, Bennet L.

J Hypertens. 2017 Dec;35(12):2493-2500. doi: 10.1097/HJH.0000000000001490.

PMID:
28731931
18.

MicroRNA-155 and Anti-Müllerian Hormone: New Potential Markers of Subfertility in Men with Chronic Kidney Disease.

Eckersten D, Tsatsanis C, Giwercman A, Bruun L, Pihlsgård M, Christensson A.

Nephron Extra. 2017 Apr 7;7(1):33-41. doi: 10.1159/000458711. eCollection 2017 Jan-Apr.

19.

Combining Cystatin C and Creatinine Yields a Reliable Glomerular Filtration Rate Estimation in Older Adults in Contrast to β-Trace Protein and β2-Microglobulin.

Werner K, Pihlsgård M, Elmståhl S, Legrand H, Nyman U, Christensson A.

Nephron. 2017;137(1):29-37. doi: 10.1159/000473703. Epub 2017 Apr 14.

PMID:
28407629
20.

Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study.

Schulz CA, Persson M, Christensson A, Hindy G, Almgren P, Nilsson PM, Melander O, Engström G, Orho-Melander M.

Kidney Int Rep. 2017 Mar;2(2):239-247. doi: 10.1016/j.ekir.2016.11.004.

21.

Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: Why to measure glomerular filtration rate with iohexol?

Delanaye P, Melsom T, Ebert N, Bäck SE, Mariat C, Cavalier E, Björk J, Christensson A, Nyman U, Porrini E, Remuzzi G, Ruggenenti P, Schaeffner E, Soveri I, Sterner G, Eriksen BO, Gaspari F.

Clin Kidney J. 2016 Oct;9(5):700-4. doi: 10.1093/ckj/sfw071. Epub 2016 Sep 9.

22.

Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: How to measure glomerular filtration rate with iohexol?

Delanaye P, Ebert N, Melsom T, Gaspari F, Mariat C, Cavalier E, Björk J, Christensson A, Nyman U, Porrini E, Remuzzi G, Ruggenenti P, Schaeffner E, Soveri I, Sterner G, Eriksen BO, Bäck SE.

Clin Kidney J. 2016 Oct;9(5):682-99. doi: 10.1093/ckj/sfw070. Epub 2016 Aug 23.

23.

The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population - the HARVEST study.

Christensson A, Grubb A, Molvin J, Holm H, Gransbo K, Tasevska-Dinevska G, Bachus E, Jujic A, Magnusson M.

Scand J Clin Lab Invest. 2016 Nov;76(7):568-574. Epub 2016 Sep 13.

PMID:
27622713
24.

High Level of Fasting Plasma Proenkephalin-A Predicts Deterioration of Kidney Function and Incidence of CKD.

Schulz CA, Christensson A, Ericson U, Almgren P, Hindy G, Nilsson PM, Struck J, Bergmann A, Melander O, Orho-Melander M.

J Am Soc Nephrol. 2017 Jan;28(1):291-303. doi: 10.1681/ASN.2015101177. Epub 2016 Jul 8.

25.

Increased Levels of Copeptin, a Surrogate Marker of Arginine Vasopressin, Are Associated with an Increased Risk of Chronic Kidney Disease in a General Population.

Tasevska I, Enhörning S, Christensson A, Persson M, Nilsson PM, Melander O.

Am J Nephrol. 2016;44(1):22-8. doi: 10.1159/000447522. Epub 2016 Jun 28.

26.

Safety and efficacy of mirabegron in daily clinical practice: a prospective observational study.

Kallner HK, Christensson AA, Elmér C, Flam B, Altman D.

Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:167-72. doi: 10.1016/j.ejogrb.2016.05.048. Epub 2016 Jun 9.

PMID:
27318184
27.

Cystatin C and Risk of Diabetes and the Metabolic Syndrome - Biomarker and Genotype Association Analyses.

Magnusson M, Molvin J, Engström G, Svensson-Färbom P, Persson M, Christensson A, Nilsson P, Melander O.

PLoS One. 2016 May 24;11(5):e0155735. doi: 10.1371/journal.pone.0155735. eCollection 2016.

28.

Anti-Müllerian hormone, a Sertoli cell-derived marker, is decreased in plasma of male patients in all stages of chronic kidney disease.

Eckersten D, Giwercman A, Bruun L, Christensson A.

Andrology. 2015 Nov;3(6):1160-4. doi: 10.1111/andr.12116. Epub 2015 Oct 9.

29.

Declining Estimated Glomerular Filtration Rate and Its Association with Mortality and Comorbidity Over 10 Years in Elderly Women.

Malmgren L, McGuigan FE, Berglundh S, Westman K, Christensson A, Åkesson K.

Nephron. 2015;130(4):245-55. doi: 10.1159/000435790. Epub 2015 Jul 15.

PMID:
26184510
30.

Cystatin C Is Not Causally Related to Coronary Artery Disease.

Svensson-Färbom P, Almgren P, Hedblad B, Engström G, Persson M, Christensson A, Melander O.

PLoS One. 2015 Jun 9;10(6):e0129269. doi: 10.1371/journal.pone.0129269. eCollection 2015.

31.

Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'.

Grubb A, Lindström V, Jonsson M, Bäck SE, Åhlund T, Rippe B, Christensson A.

Scand J Clin Lab Invest. 2015 Jul;75(4):333-40. doi: 10.3109/00365513.2015.1025427.

32.

Male patients with terminal renal failure exhibit low serum levels of antimüllerian hormone.

Eckersten D, Giwercman A, Christensson A.

Asian J Androl. 2015 Jan-Feb;17(1):149-53. doi: 10.4103/1008-682X.135124.

33.

Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator.

Grubb A, Horio M, Hansson LO, Björk J, Nyman U, Flodin M, Larsson A, Bökenkamp A, Yasuda Y, Blufpand H, Lindström V, Zegers I, Althaus H, Blirup-Jensen S, Itoh Y, Sjöström P, Nordin G, Christensson A, Klima H, Sunde K, Hjort-Christensen P, Armbruster D, Ferrero C.

Clin Chem. 2014 Jul;60(7):974-86. doi: 10.1373/clinchem.2013.220707. Epub 2014 May 14.

34.

Family history of myocardial infarction increases risk of renal dysfunction in middle age.

Christensson A, Melander O, Fjellstedt E, Ohlson-Andersson M.

Am J Nephrol. 2014;39(2):85-91. doi: 10.1159/000358259. Epub 2014 Jan 30.

PMID:
24481112
35.

Male sex and vascular risk factors affect cystatin C-derived renal function in older people without diabetes or overt vascular disease.

Werner KB, Elmståhl S, Christensson A, Pihlsgård M.

Age Ageing. 2014 May;43(3):411-7. doi: 10.1093/ageing/aft191. Epub 2013 Dec 8.

36.

Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease.

Svensson-Färbom P, Ohlson Andersson M, Almgren P, Hedblad B, Engström G, Persson M, Christensson A, Melander O.

J Intern Med. 2014 May;275(5):506-21. doi: 10.1111/joim.12169. Epub 2013 Dec 20.

37.

Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility.

Grundström G, Christensson A, Alquist M, Nilsson LG, Segelmark M.

BMC Nephrol. 2013 Oct 9;14:216. doi: 10.1186/1471-2369-14-216.

38.

[Regional guidelines for preventative nephrology have been well received].

Clyne N, Christensson A, Ervander C, Ilestam G, Tyrberg S, Akerberg A.

Lakartidningen. 2013 May 22-28;110(21):1033-6. Swedish. No abstract available.

PMID:
23805769
39.

[Time for new measurements in kidney disease diagnosis and follow-up].

Grubb A, Christensson A.

Lakartidningen. 2013 May 22-28;110(21):1021-4. Review. Swedish. No abstract available.

PMID:
23805765
40.

Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years.

Christensson A, Savage C, Sjoberg DD, Cronin AM, O'Brien MF, Lowrance W, Nilsson PM, Vickers AJ, Russo P, Lilja H.

Int J Cancer. 2013 Sep 15;133(6):1452-8. doi: 10.1002/ijc.28144. Epub 2013 Mar 29.

41.

Preparatory studies to a population-based survey of suicide-bereaved parents in Sweden.

Omerov P, Steineck G, Runeson B, Christensson A, Kreicbergs U, Pettersén R, Rubenson B, Skoogh J, Rådestad I, Nyberg U.

Crisis. 2013;34(3):200-10. doi: 10.1027/0227-5910/a000175.

PMID:
23261907
42.

Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome.

Ristiniemi N, Lund J, Tertti R, Christensson A, Ilva T, Porela P, Pulkki K, Pettersson K.

Clin Biochem. 2012 May;45(7-8):535-40. doi: 10.1016/j.clinbiochem.2012.02.012. Epub 2012 Feb 27.

PMID:
22394460
43.

Evaluation of a new immunoassay for cystatin C, based on a double monoclonal principle, in men with normal and impaired renal function.

Ristiniemi N, Savage C, Bruun L, Pettersson K, Lilja H, Christensson A.

Nephrol Dial Transplant. 2012 Feb;27(2):682-7. doi: 10.1093/ndt/gfr350. Epub 2011 Jun 15.

44.

Achievement of recommended treatment targets for bone and mineral metabolism in haemodialysis patients using paricalcitol: an observational study.

Fernström A, Giæver J, Granroth B, Hylander B, Jensen G, Christensson A, Wikström B, Weiss L, Wrege U, Jacobson SH.

Scand J Urol Nephrol. 2011 Apr;45(3):196-205. doi: 10.3109/00365599.2011.553738. Epub 2011 Mar 2.

PMID:
21366390
45.

Editorial comment. Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen.

Christensson A, Lilja H.

Urology. 2010 Nov;76(5):1046-7; author reply 1047. doi: 10.1016/j.urology.2009.06.057. No abstract available.

46.

Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer.

Christensson A, Bruun L, Björk T, Cronin AM, Vickers AJ, Savage CJ, Lilja H.

BJU Int. 2011 Jun;107(11):1769-74. doi: 10.1111/j.1464-410X.2010.09761.x. Epub 2010 Oct 18.

47.

Estimation of the age-dependent decline of glomerular filtration rate from formulas based on creatinine and cystatin C in the general elderly population.

Christensson A, Elmståhl S.

Nephron Clin Pract. 2011;117(1):c40-50. doi: 10.1159/000319646. Epub 2010 Aug 4.

PMID:
20689324
48.

Change in depressive symptoms over higher education and professional establishment - a longitudinal investigation in a national cohort of Swedish nursing students.

Christensson A, Runeson B, Dickman PW, Vaez M.

BMC Public Health. 2010 Jun 15;10:343. doi: 10.1186/1471-2458-10-343.

49.

Self-reported depression in first-year nursing students in relation to socio-demographic and educational factors: a nationwide cross-sectional study in Sweden.

Christensson A, Vaez M, Dickman PW, Runeson B.

Soc Psychiatry Psychiatr Epidemiol. 2011 Apr;46(4):299-310. doi: 10.1007/s00127-010-0198-y. Epub 2010 Mar 7.

PMID:
20213328
50.

Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.

Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engström G, Persson M, Smith JG, Magnusson M, Christensson A, Struck J, Morgenthaler NG, Bergmann A, Pencina MJ, Wang TJ.

JAMA. 2009 Jul 1;302(1):49-57. doi: 10.1001/jama.2009.943.

Supplemental Content

Loading ...
Support Center